AWM
DNTH icon

Aries Wealth Management’s Dianthus Therapeutics DNTH Stock Holding History

Aries Wealth Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,125
Closed -$131K – 191
2021
Q3 		$131K Hold
1,125
– – 0.06% 173
2021
Q2 		$176K Hold
1,125
– – 0.08% 177
2021
Q1 		$198K Hold
1,125
– – 0.09% 169
2020
Q4 		$152K Buy
1,125
+375
+50% +$42.5K 0.08% 157
2020
Q3 		$82K Hold
750
– – 0.05% 146
2020
Q2 		$90K Hold
750
– – 0.05% 139
2020
Q1 		$77K Hold
750
– – 0.06% 127
2019
Q4 		$177K Hold
750
– – 0.11% 151
2019
Q3 		$118K Hold
750
– – 0.08% 149
2019
Q2 		$165K Hold
750
– – 0.12% 152
2019
Q1 		$198K Buy
+750
New +$129K 0.15% 146

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aries Wealth Management's DNTH Position: Q4 2021 in Review

Aries Wealth Management sold out of Dianthus Therapeutics (DNTH) in Q4 2021, closing a stake of 1,125 shares — an estimated $131K sold.

Aries Wealth Management first reported a position in DNTH in Q1 2019 and held it in 11 quarters. The position peaked at $198K in Q1 2021. 94 funds tracked by Wall St. Rank hold DNTH as of Q4 2021.

  • Aries Wealth Management reported no remaining Dianthus Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Aries Wealth Management sold 1,125 Dianthus Therapeutics shares in Q4 2021, an estimated $131K.
  • Aries Wealth Management first reported a position in Dianthus Therapeutics in Q1 2019 and held it in 11 quarters.
  • Aries Wealth Management's Dianthus Therapeutics position peaked at $198K in Q1 2021.
  • 94 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q4 2021.

Based on Aries Wealth Management's 13F filing for Q4 2021, filed 18 Jan 2022.